 CEO Tim Wentworth told analysts Thursday morning that changes are imminent for about 25% of the company's stores, which he said were underperforming. The drugstore chain currently runs more than 8,600 in the United States. Wentworth said the company's plan could include the closing of a significant portion of some 2,100 stores. Keith Peters reporting.